December 1, 2011
Table of Contents
As an action-packed year for the HIV/AIDS community draws to a close, TheBody.com takes stock of 2011 in a new series of articles, "2011 HIV/AIDS Year in Review." Read the entire series here.
A year can seem like a long time. When our planet was last where it is now relative to the sun, the spewing remnants of the BP Deepwater Horizon rig had just been capped, mid-term elections handed the GOP the keys to the House, and a new-fangled device called the iPad had been in stores for only a few months. In our smaller orbit of HIV-related news, it can be hard to appreciate where we were just a year ago. Below are some of the stories that marked our journey through 2011 and, in some way, changed things from the way they used to be.
No comments have been made.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.
|Long-Acting HIV Treatment: 5 Myths and Realities|
|IL-1β Inhibitor Lowers Arterial Inflammation in Adults With Controlled HIV|
|Two-Drug HIV Treatment Regimens Effective in Latest Studies|
|The Need to Advocate for Fair HIV Drug Prices|
|Weekly Injections of Antibody PRO 140 Keep HIV Undetectable in 10 of 16 Patients|
|'Stop Describing, Start Intervening': Can the CDC's New Viral Load Data Help Guide HIV Programs?|